Inceptor Bio is committed to building and advancing a pipeline of programs based on diversified cell therapies including CAR-M, CAR-T, and CAR-NK. This is the new frontier in the immune-oncology arsenal and we are dedicated to our vision of these programs bringing a more positive prognosis and quality of life to patients with difficult-to-treat cancers.
